Global Endorphins Sales Market Report 2021

Endorphins are also known as “feel-good” or natural pain relievers. They are produced by the central nervous system and pituitary gland. Endorphins are released in response to stress or pain. They work similarly to a class of drugs called opioids. However, endorphins work similarly to opioid pain reliver, but their result may not dramatic. Besides, they are also released during other activities such as exercise, eating and others activities. Endorphins are also surge during pregnancy. Further, there are various medicinal herbs such as Rhodiola roseal, is known to release beta-endorphins in the brain and also used against an anti-depressant.

Market Analysis and Insights: Global Endorphins Market
The global Endorphins market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Endorphins Scope and Market Size
The global Endorphins market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Endorphins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Alpha-Endorphins
Beta-Endorphins
Gamma-Endorphins
Sigma-Endorphins

Segment by Application
Institutional Pharmacies
Retail Pharmacies
Online Pharmacies

The Endorphins market is analysed and market size information is provided by regions (countries). Segment by Application, the Endorphins market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Endo International Plc
Egalet Corp.
Lannett Co. Inc.
Pfizer
Johnson & Johnson